Moscow (AFP) | 07/07/2025 - 15:31:36 | Russian minister kills himself hours after being fired by Putin: state media
Sanaa (AFP) | 07/07/2025 - 15:21:34 | Yemen's Huthis claim Sunday attack on commercial ship in Red Sea
Tehran (AFP) | 07/07/2025 - 15:15:20 | Iran president says 'no problem' restarting nuclear talks with US
Tehran (AFP) | 07/07/2025 - 14:57:06 | Iran president says Israel attempted to assassinate him
Hunt, Texas (AFP) | 07/07/2025 - 14:37:07 | Camp Mystic says 27 campers and counselors died in Texas flood
Brussels (AFP) | 07/07/2025 - 12:29:49 | EU chief, Trump had 'good exchange' by phone Sunday
Beirut (AFP) | 07/07/2025 - 12:12:11 | US envoy says satisfied with Lebanese response on disarming of Hezbollah
Moscow (AFP) | 07/07/2025 - 11:33:03 | Russia says captured first village in Ukraine's Dnipropetrovsk region
Kyiv (AFP) | 07/07/2025 - 10:52:41 | Ukraine army says Russian strikes hit two recruitment centres
Beijing (AFP) | 07/07/2025 - 09:21:31 | China says BRICS not seeking 'confrontation' after Trump tariff threat
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
AFP takes part to the 7th photography festival in Leipzig f/stop, Germany, from June 25th until July 3rd, 2016.
The Asian Productivity Organization (APO) convened the 67th Session of the Governing Body (GBM), 20–22 May 2025 in Jakarta, hosted by the Government of the Republic of Indonesia. This annual session brought together over 50 delegates representing APO member governments to discuss the APO’s strategic direction and ensure the organization’s continued credibility, effectiveness, and relevance amid a rapidly evolving productivity landscape. This press release features multimedia. View the full rel...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human antibody mouse platform has been granted an invention patent by the Japan Patent Office (JPO). This milestone marks a significant step in strengthening the global intellectual property portfolio of the RenMice® fully human antibody platform family. It underscores the continued advancement of Biocytogen’s comprehensive ...
